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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYSomatic cells can be reprogrammed to pluripotency using different methods. In comparison with pluripotent cells obtained through so-
matic nuclear transfer, induced pluripotent stem cells (iPSCs) exhibit a higher number of epigenetic errors. Furthermore, most of these
abnormalities have been described to be intrinsic to the iPSC technology. Here, we investigate whether the aberrant epigenetic patterns
detected in iPSCs are specific to transcription factor-mediated reprogramming. We used germline stem cells (GSCs), which are the only
adult cell type that can be converted into pluripotent cells (gPSCs) under defined culture conditions, and compared GSC-derived iPSCs
and gPSCs at the transcriptional and epigenetic level. Our results show that both reprogramming methods generate indistinguishable
states of pluripotency. GSC-derived iPSCs and gPSCs retained similar levels of donor cell-type memory and exhibited comparable
numbers of reprogramming errors. Therefore, our study demonstrates that the epigenetic abnormalities detected in iPSCs are not specific
to transcription factor-mediated reprogramming.INTRODUCTION
Previous studies have reported that induced pluripotent
stem cells (iPSCs) retain epigenetic traits of the tissue of
origin and accumulate DNA methylation errors during
the reprogramming process (Kim et al., 2010; Ma et al.,
2014). However, whether these epigenetic abnormalities
are a consequence of cellular reprogramming per se or
are specific to the iPSC technology remains controversial.
A previous study has shown that most of the abnormal-
ities found in iPSCs are introduced during the reprogram-
ming process (Ma et al., 2014). Indeed, iPSCs exhibit
more aberrations than pluripotent cells obtained through
somatic cell nuclear transfer (SCNT) (Ma et al., 2014). In
this study, we used a third reprogramming method to
investigate whether iPSC epigenetic errors are a conse-
quence of the ectopic expression of transcription factors.
Germline stem cells (GSCs) are the only adult cell type
that can be converted into pluripotent stem cells, termed
germline pluripotent stem cells (gPSCs), under specific
culture conditions (Ko et al., 2009). Thus, we compared
GSC-derived iPSCs with gPSCs at the transcriptional
and epigenetic level. Global gene expression and
genome-wide DNA methylation analysis confirmed that
GSC-derived iPSCs and gPSCs exhibit similar levels of
donor memory and de novo reprogramming errors.
Therefore, our results indicate that epigenetic aberra-
tions are not specific to transcription factor-mediated
reprogramming.StemRESULTS
Conversion of GSCs to Pluripotency Using Two
Different Reprogramming Methods
We derived two GSC lines, named GSC #1 and #2, from
mice containing an Oct4-GFP reporter transgene (Yoshi-
mizu et al., 1999). Next, we reprogrammed both GSC lines
to pluripotency using two different methods (Figure 1A).
First, doxycycline-inducible lentiviruses coding for Oct4,
Sox2, Kfl4, and Myc, together with a reverse tetracycline
transactivator (Brambrink et al., 2008), were used to
generate iPSCs from both GSC lines.Oct4-GFP-positive col-
onies emerged 5–8 days after transgene induction.
Although a previous study reported the inability to
generate GSC-derived iPSCs using constitutively expressed
lentiviruses (Morimoto et al., 2012), we were able to repro-
gram GSCs into iPSCs using inducible lentiviruses (for
details see Supplemental Experimental Procedures). In par-
allel, iPSCs were generated from fibroblasts (Fib) from the
same mouse line and following the same procedure. Inter-
estingly, Fib-iPSC colonies were not observed until 10–
20 days after doxycycline induction, demonstrating that
GSCs are reprogrammed significantly faster than other so-
matic cell types. As previously reported, the stoichiometry
of the reprogramming factors influences the iPSC genera-
tion rate. Indeed, a high relative level of both Oct4 and
Klf4 combined with a low relative level of Sox2 and Myc
has been described to increase the reprogramming effi-
ciency (Tiemann et al., 2011). Accordingly, GSCs wereCell Reports j Vol. 6 j 35–43 j January 12, 2016 j ª2016 The Authors 35
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reprogrammed into iPSCs 5-fold more efficiently after
using higher ratios of both Oct4 and Klf4, whereas a lower
ratio of these two factors completely prevented iPSC induc-
tion (Figure S1A). Four tetracycline-independent, Oct4-
GFP-positive iPSC cell lines were established and termed
iPSC #1, #2, #3, and #4 (Figure 1A). Integration of all four
lentiviral transgenes was detected in all generated iPSC
lines using PCR-based genotyping (Figure S1B).
Second, GSC lines #1 and #2 were reprogrammed into
gPSCs under specific culture conditions, as previously re-
ported (Ko et al., 2010). Oct4-GFP-positive colonies were
observed after 6–8 weeks (Figure 1A). Four gPSC lines
were derived from single-cell colonies and named gPSC
#1, #2, #3, and #4 (Figure 1A). As expected, we did not
detect any lentiviral transgenes in the generated gPSC lines
(Figure S1B). In total, eight different reprogrammed cell
lines corresponding to four independent iPSC and gPSC
clones were subsequently analyzed at an early stage (pas-
sage 5) and late stage (passage 35) after reprogramming
(Figure 1A).
Next, we characterized the pluripotency of the reprog-
rammed iPSC and gPSC lines. To this end, the presence
of several pluripotency-specific proteins was assessed. In
contrast to the parental GSCs, the generated iPSC and
gPSC lines strongly expressed the Oct4-GFP transgene and
stained positive for the pluripotent markers NANOG
and alkaline phosphatase (Figure 1B). In addition, the tran-
scriptional levels of the endogenous pluripotent markers
Oct4, Sox2, Nanog, and Esrrb were analyzed by qRT-PCR
(Figure S2A). All iPSC and gPSC clones exhibited expression
levels similar to those of embryonic stem cells (ESCs) and
different from those of the initial GSC population, demon-
strating a successful reprogramming to pluripotency.
Furthermore, all iPSC and gPSC lines showed a normal
karyotype (Figure S2B). Finally, we investigated the devel-
opmental potential of the generated iPSC and gPSC lines.
After undirected differentiation using embryoid bodies,Figure 1. Conversion of GSCs to Pluripotency Using Two Differen
(A) Schematic overview and timeline summarizing cell line derivation
iPSCs emerged at least 5 weeks earlier than gPSCs. In both cases, DNA
and cell line establishment. At these time points, iPSCs and gPSCs had
cells; iPSC, induced pluripotent stem cells; gPSC, germline-derived plu
passage number.
(B) Oct4-GFP reporter fluorescence (green, phase-contrast overlay),
Hoechst staining), and alkaline phosphatase (ALP) activity assay (red
stem cells; Fib-iPSC, iPSCs derived from fibroblasts. Scale bars, 50 mm
(C) Representative images of Oct4-GFP-positive GSC-derived pluripote
after integration into the inner cell mass of a 3.5-DPC blastocyst.
(D) Chimeric embryos (14.5 DPC) showing Oct4-GFP-positive contribu
several organs (PCR genotyping). br, brain (ectoderm); he, heart (meso
250 mm.
See also Figures S1 and S2, and Tables S2 and S3.
Stemall cell lines stained positive for TUBB3 (ectoderm),
ACTA2 (mesoderm), and SOX17 (endoderm), thus proving
their ability to differentiate in vitro into cell types of all
three germ layers (Figure S2C). Moreover, iPSC and gPSC
lines were aggregated with morula-stage embryos to assess
their potential to generate chimeric embryos in vivo. The
following day, Oct4-GFP-positive cells had integrated into
the blastocyst inner cell mass (Figure 1C). All tested iPSC
and gPSC lines were able to contribute to the germline as
shown by the presence ofOct4-GFP-positive cells in the go-
nads of embryos 14.5 days post coitum (DPC). Further-
more, Oct4-GFP genotyping revealed that iPSCs and gPSCs
were able to contribute to brain (ectoderm), heart (meso-
derm), and liver (endoderm), indicating their capacity to
differentiate into all three germ layers in vivo (Figure 1D).
Taken together, these results demonstrate that all analyzed
iPSC and gPSC lines are bona fide pluripotent cells.
Global Gene Expression Profiling of iPSCs and gPSCs
To investigate whether the two studied reprogramming
methods exhibit different potentials to remodel the initial
GSC transcriptional network, we recorded the global gene
expression profile of the generated iPSC, gPSC, and control
cell lines using microarray analysis. We decided to analyze
the reprogrammed cell lines at passage 5, since donor cell-
type transcriptional memory in iPSCs has been reported to
be predominant at early passages (Polo et al., 2010). A prin-
cipal-component analysis revealed that all reprogrammed
cell lines clustered together with ESCs independently of
the reprogramming method (iPSCs versus gPSCs) or the
donor cell type (GSCs versus Fib) (Figure 2A). An unsuper-
vised hierarchical clustering further substantiated that
the different pluripotent samples could not be distin-
guished based on the method used for reprogramming.
Remarkably, the replicate samples of gPSC #4 and Fib-
iPSC that are derived from different cell types and using
different techniques could not be separated, furthert Reprogramming Methods
and analysis. iPSC and gPSC induction was performed in parallel, but
and RNA were collected at passages 5 and 35 after colony isolation
been cultured for an equivalent period of time. GSC, germline stem
ripotent stem cells; Tet, tetracycline-inducible; Dox, doxycycline; p,
immunological staining for NANOG (red, overlay with blue nuclear
chromogene fluorescence, phase-contrast overlay). ESC, embryonic
.
nt cells after aggregation with a 2.5-DPC morula-stage embryo and
tion in the fetal gonads and positive GFP transgene contribution to
derm); li, liver (endoderm). Black scale bars, 5 mm; white scale bars,
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demonstrating the similarity of the different pluripotent
cell lines (Figure 2B).
Next, we sought to investigate the expression pattern of
GSC-specific genes in the iPSC and gPSC lines. To this end,
we screened the microarray data for genes that were
strongly expressed in both GSC lines but not in ESCs or
Fib. Most of these GSC-specific genes were downregulated
in all iPSC and gPSC lines, indicating that both reprogram-
ming methods can effectively erase the GSC-specific tran-
scriptional signature (Figure 2C). Only the expression of a
few GSC-specific markers such as Spint5, Gbp3, Dazl, Vasa,
Piwil2, and Fkbp6 could still be detected in some cell lines.
These results were confirmed by qRT-PCR (Figure 2D). As
previous studies have reported that the initial transcrip-
tional memory in iPSCs can be attenuated after continuous
passaging (Polo et al., 2010), we also measured the expres-
sion of these GSC-specific markers at a later passage (pas-
sage 35) by qRT-PCR. In fact, all reprogrammed cell lines
had downregulated the expression of the studied GSC-
specific markers at passage 35 (Figure 2D). Therefore, the
transcriptomes of both iPSCs and gPSCs were fully reprog-
rammed at late passage, independently of themethod used
for reprogramming.
Genome-Wide DNA Methylation Analysis of iPSCs
and gPSCs
Several reports have shown that iPSCs with a fully reprog-
rammed transcriptome can still exhibit epigenetic abnor-
malities (Kim et al., 2010; Ma et al., 2014). In this context,
we performed a genome-wide DNA methylation analysis
using reduced-representation bisulfite conversion and sub-
sequent next-generation sequencing (RRBSeq) (Meissner
et al., 2005) in two iPSC clones (iPSC #1 and iPSC #2),
two gPSC clones (gPSC #1 and gPSC #2), the initial GSC
#1 and GSC #2 lines, and three ESC controls (ESC #1 was
derived from Oct4-GFP transgenic mice, whereas ESC #2
and ESC #3 were derived from a different genetic back-
ground) (Table S1). Next, we determined the number of
differentially methylated regions (DMRs) for each sample
in comparison with the ESC #1 reference sample. Our anal-Figure 2. Global Gene Expression Profiling of iPSCs and gPSCs
(A) Principal-component analysis of the global transcriptomes (micro
components (P. C.) that contribute most strongly to the overall varianc
of variance, as indicated. Two replicates for each clonal cell line wer
(B) Dendrogram displaying the results of an unsupervised hierarchic
expression profiles. Two technical replicates for each cell line were a
(C) Heatmap showing the expression of GSC-specific marker genes in re
the average of the two GSC controls. Red and green colors represent
respectively.
(D) Validation of the microarray data presented in (C) by qRT-PCR for s
late passage (p 35). Error bars indicate SD of the mean (technical rep
See also Table S3.
Stemysis identified twice as many DMRs in GSCs (average
219,446) as in iPSCs (average 87,028) or gPSCs (average
84,925). Remarkably, we also identified a high number of
DMRs between ESC #1 and ESC #2 or ESC #3 (average
206,950). Therefore, the epigenetic differences between re-
programmed cells and ESC #1 were considerably smaller
than the epigenetic variation among ESCs from different
genetic backgrounds (Figure 3A). On average, 63% of the
identified DMRs were located in the context of annotated
genes (Figure 3B). In addition, the DMR distribution
among the different chromosomes was very similar in all
the studied cell lines (Figure 3C).
Furthermore, we analyzed themethylation level of DMRs
located within GSCmarker genes that are transcriptionally
silenced during conversion to pluripotency, as shown in
Figure 2C. The gene Brdt contained a completely demethy-
lated DMR inGSCs, which was completely remethylated to
an ESC-like level in all analyzed iPSC and gPSC lines. In
contrast, DMRs associated with other genes such as Irf8,
Dapk2, Foxf1, Wt1, and C1qtnf4 exhibited hypomethyla-
tion in GSCs but did not fully regain an ESC-like methyl-
ation level in all reprogrammed cell lines (Figure 3D). Simi-
larly, DMRs within pluripotency marker genes that are
highly methylated in GSCs such as Zscan10 (Zfp206) and
L1td1 (ECAT11) lost their GSC-like methylation in most
but not all reprogrammed cell lines. The genes Esrrb and
Cdh1 (E-cadherin) contain DMRs that even remained
almost completely methylated in all iPSC and gPSC lines
(Figure 3D). Thus, our results demonstrate that reprog-
rammed cells partially retain donor-like DNA methylation
patterns despite their fully ESC-like transcription profiles.
Finally, an unsupervised hierarchical clustering including
all gene-associated DMRs that are differently methylated
between GSCs and ESCs showed that all reprogrammed
cell lines cluster together with ESC #1, demonstrating
that pluripotent cell lines could be separated based on their
genetic background but not based on the reprogramming
method (Figure 3E).
We next sought to quantitatively assess how many of
the identified DMRs in iPSCs and gPSCs correspond to aarray, passage 5) of iPSCs, gPSCs, and controls. The three principal
e are shown. Axes are scaled proportionally to the explained portion
e averaged and are represented by a single circle. Fib, fibroblasts.
al clustering based on the overall correlation among global gene
nalyzed independently.
programmed clonal cell lines. Signal intensities were normalized to
higher and lower gene expression levels in comparison with GSCs,
elected GSC markers, normalized to ESC #1. E, early passage (p 5); L,
licates, n = 3).
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Figure 3. Genome-Wide DNA Methylation
Analysis of iPSCs and gPSCs
(A) Differentially methylated regions
(DMRs) in the analyzed cell lines. Hyper-
and hypomethylated regions exhibit
a R50% higher or lower CpG methylation
rate compared with the ESC #1 control,
respectively. GSCs, average of GSC #1 and
GSC #2; ESCs, average of ESC #2 and ESC #3.
(B) Mapping of DMRs to different genomic
contexts. Relative frequencies of DMRs
located in promoters, exons, introns, and
outside of annotated genes are shown in
comparison with the ESC #1 control (all
identified DMRs = 100%).
(C) Chromosomal mapping of DMRs. Relative
frequencies of DMRs are shown in compari-
son with the ESC #1 control (all identified
DMRs = 100%). mt, mtDNA.
(D) Sets of GSC-specific markers and plu-
ripotency markers were investigated for the
presence of DMRs. Hypo- and hyper-
methylation relative to the ESC #1 control
are displayed by red and blue colors in the
heatmaps, respectively.
(E) Dendrogram displaying the results of an
unsupervised hierarchical clustering based
on hyper- and hypomethylated genes that
distinguish GSCs and ESCs.
(F) Numbers of hyper- and hypomethylated
DMR-containing genes in the individual
iPSC and gPSC clones relative to the ESC #1
control are displayed by differently sized
circles. Yellow circular sectors represent
DMRs that are also hyper- or hypomethy-
lated in GSC #1 and/or GSC #2 relative to ESC
#1, thus corresponding to donor cell-type
memory. Green-framed sectors represent
DMRs that are also hyper- or hypomethy-
lated in ESC #2 and/or ESC #3 relative to
ESC #1, indicating variability among the
different ESCs. Red, purple, blue, and cyan
sectors represent DMRs that are hyper- or
hypomethylated in iPSCs and gPSCs but
not in GSCs or ESCs, thus representing re-
programming errors. Percentages of puta-
tive donor memory (shared with GSCs but
not variable among ESCs) and putative de
novo introduced reprogramming errors (not
shared with GSCs and not variable among
ESCs) are indicated.
See also Table S1.
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residual memory of the tissue of origin or to errors de novo
introduced during the reprogramming process. First, genes
that were hypermethylated or hypomethylated in iPSCs or
gPSCs and in at least one GSC line (relative to ESC #1) were
considered to represent residual GSC-specific epigenetic
memory. Here, we excluded genes differently methylated
between ESC #1 and ESC #2 or ESC #3, which can be
considered as generally variable in the pluripotent state.
Our results indicate that 23.3%–27.8% of the hypermethy-
lated and 48.3%–49.28% of the hypomethylated genes in
iPSCs and gPSCs correspond to a donor-specific epigenetic
signature (Figure 3F). Second, genes that were hypermethy-
lated or hypomethylated in iPSCs or gPSCs but not in GSCs
(relative to ESC #1) were considered to be epigenetic errors
de novo introduced during the reprogramming process.
Again, genes differently methylated between ESC #1 and
ESC #2 or ESC #3 were excluded. Our analysis shows that
54.7%–57.9% of the hypermethylated genes and 29.1%–
33.3% of the hypomethylated genes in iPSCs and gPSCs
correspond to reprogramming errors (Figure 3F). Overall,
these results indicate that hypomethylated DMRs in iPSCs
and gPSCs are mainly due to a donor-specific memory,
whereas the majority of hypermethylated DMRs probably
reflect errors acquired during the reprogramming process.
Importantly, the ratio between epigenetic memory and re-
programming errors is very consistent in all analyzed iPSC
and gPSC lines, demonstrating that the reprogramming
method influences neither the amount of donor cell-type
memory nor the de novo introduction of epigenetic aberra-
tions during the acquisition of pluripotency.DISCUSSION
In this study we have investigated whether epigenetic ab-
normalities are specific to the transcription factor-medi-
ated reprogramming method. To this end, we took advan-
tage of GSCs, which can be reprogrammed using the iPSC
technology or defined culture conditions. Our results
show that iPSCs and gPSCs are indistinguishable at the
transcriptional and epigenetic levels. In addition, we also
tried to reprogram GSCs using SCNT. However, we could
not obtain a single blastocyst-stage embryo after recon-
structing 1,000 enucleated oocytes with GSC nuclei
(data not shown). We excluded the GSC androgenetic
imprinting as the cause underlying the SCNT reprogram-
ming failure, since primary spermatocytes have been suc-
cessfully used in nuclear transfer experiments (Zhao et al.,
2010). Hence, further experiments are required to elucidate
the inability to reprogram GSCs using nuclear transfer. To
date, the reprogramming of stable GSC lines into iPSCs
was considered not to be feasible (Morimoto et al., 2012).
However, we succeeded in reprogramming GSCs into iPSCsStemat very low efficiencies after optimizing the transduction
protocol. We expected GSCs to be an easily reprogram-
mable cell type, since GSCs express several pluripotency-
related transcripts and exhibit hypomethylation in
promoters of pluripotency genes (Imamura et al., 2006).
However, GSCs are reluctant to nuclear transfer, and
GSC-derived iPSCs can only be generated at very low fre-
quencies. GSCs are the only adult cell type known to ex-
press OCT4 protein, albeit at low levels. We speculate
that an increase in the OCT4 levels might trigger testicular
teratoma formation due to the similarities between iPSC in-
duction and tumor formation (Tapia and Scho¨ler, 2010).
Therefore, we hypothesize that GSCs might have a specific
mechanism to prevent in vivo reprogramming, which in
turn hinders in vitro reprogramming.
Previously, we have shown that fibroblasts can be con-
verted into induced neural stem cells (Kim et al., 2014),
which can be reprogrammed to pluripotency in a subse-
quent step (Marthaler et al., 2013).Our resultsdemonstrated
that the pluripotent state could erase the donor cell type
transcriptional memory more efficiently than the somatic
stem cell state, suggesting that thefinal developmental state
achieved after reprogramming might have a higher impact
on the level of residual memory than the reprogramming
method itself. Consistently, gPSCs and iPSCs retain the
same levels of donor-specific memory since both methods
reprogram differentiated cells directly to pluripotency. In
contrast, the totipotency state reached during SCNT might
explain that SCNT-derived pluripotent cells exhibit lower
levels of epigenetic memory than iPSCs (Ma et al., 2014).
Recently, iPSC inductionhasbeendescribedtooccur invivo.
Interestingly, in vivo reprogrammed iPSCs exhibit totipo-
tency features that are absent in iPSCs generated in vitro
(Abad et al., 2013). A genome-wide DNAmethylation anal-
ysis of these invivo iPSCsmightclarifywhether thedevelop-
mental potential, and not the reprogramming method, is
the main player erasing the cell-of-origin epigenetic traits.
The potential use of transcription factor-mediated
reprogramming in cell-replacement therapy, disease
modeling, and drug discovery can be compromised due to
the epigenetic abnormalities described in iPSCs. Human
nuclear transferhasbeen reported as analternative toYama-
naka’s approach (Tachibana et al., 2013). Although both
methods introduce comparable levels of de novo coding
mutations and imprinting aberrations in the final pluripo-
tent cells (Johannesson et al., 2014), nuclear transfer has
been claimed to generate fewer reprogramming errors (Ma
et al., 2014). However, SCNT generates autologous pluripo-
tent cells with allogenic mitochondria. Thus, our reprog-
ramming goal should be to reach an SCNT-like pluripotent
state using iPSC technology. Our study shows that gPSCs
and iPSCs retain similar levels of donor cell-type memory
and exhibit comparable numbers of reprogramming errors,Cell Reports j Vol. 6 j 35–43 j January 12, 2016 j ª2016 The Authors 41
excluding the nonphysiological expression levels of exoge-
nous transcription factors as the cause underlying the dif-
ferences observed between SCNT ESCs and iPSCs. There-
fore, our results indicate that epigenetic aberrations are
not specific to transcription factor-mediated reprogram-
ming. Further experiments will need to determine whether
the totipotent state generated during nuclear transfer or
specific factors present in the oocyte are responsible for
the highest reprogramming fidelity observed in SCNT-
derived pluripotent cells.EXPERIMENTAL PROCEDURES
Full details are given in the Supplemental Experimental Procedures.
Cell Line Generation and Culture
Establishment and culture of GSCs, ESCs, and fibroblasts was per-
formed as previously described (Ko et al., 2010, 2012). Animal
handling was in accordance with the Max Planck Society animal
protection guidelines and the German animal protection laws.
GSC-iPSCs were generated by transduction with tetracycline-
inducible lentiviruses coding for Oct4, Sox2, Klf4, and Myc plus a
reverse tetracycline transactivator (Brambrink et al., 2008). Cul-
ture-induced reprogramming of GSCs into gPSCs was performed
following a previously reported protocol (Ko et al., 2010).
Characterization of Pluripotent Cell Lines
Stainings, karyotyping, and chimera formation were conducted as
previously described (Fischedick et al., 2012). In vitro differentia-
tionwas performed after embryoid body formation as reported pre-
viously (Tiemann et al., 2014). Antibodies are listed in Table S2.
The primer sequences for PCR genotyping and SYBR Green qRT-
PCR are summarized in Table S3. Microarray analysis (MouseRef
8 v2.0 Expression BeadChips; Illumina) was conducted as previ-
ously described (Ko et al., 2011). Next-generation RRBSeq DNA
methylation analysis was performed on an Illumina HiSeq plat-
form by GATC Biotech. For details regarding the analysis of global
transcriptional and DNA methylation data, see Supplemental
Experimental Procedures.
ACCESSION NUMBERS
The NCBI GEO database (http://www.ncbi.nlm.nih.gov/gds)
accession number for the microarray and RRBSeq data reported
in this paper is GEO: GSE66613.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, two figures, and three tables and can be found
with this article online at http://dx.doi.org/10.1016/j.stemcr.
2015.11.007.
AUTHOR CONTRIBUTIONS
U.T., H.R.S., and N.T. conceived the study; U.T. conducted the ex-
periments and analyzed the data; G.W. performed embryo aggrega-42 Stem Cell Reports j Vol. 6 j 35–43 j January 12, 2016 j ª2016 The Authortions and nuclear transfer; A.G.M. performed karyotyping; U.T.,
H.R.S., and N.T. interpreted the results and wrote the manuscript.ACKNOWLEDGMENTS
We are grateful to Marcos Arau´zo-Bravo (BioDonostia Health
Research Institute, Spain) for his helpful advice on microarray
data analysis. We thank Michele Boiani (Max Planck Institute for
Molecular Biomedicine, Germany) and Teruhiko Wakayama (Uni-
versity of Yamanashi, Japan) for their efforts on the SCNT experi-
ments. psPAX2 and pMD2 were gifts from D. Trono. The Max
Planck Society is funding H.R.S.’s group, whereas the North-Rhine
WestphaliaMinistry of Innovation, Science and Research as well as
the Heinrich Heine University Du¨sseldorf are funding N.T.’s Junior
Research Group.
Received: March 14, 2015
Revised: November 12, 2015
Accepted: November 18, 2015
Published: December 17, 2015REFERENCES
Abad, M., Mosteiro, L., Pantoja, C., Canamero, M., Rayon, T., Ors,
I., Grana, O., Megias, D., Dominguez, O., Martinez, D., et al.
(2013). Reprogramming in vivo produces teratomas and iPS cells
with totipotency features. Nature 502, 340–345.
Brambrink, T., Foreman, R., Welstead, G.G., Lengner, C.J., Wernig,
M., Suh, H., and Jaenisch, R. (2008). Sequential expression of plu-
ripotency markers during direct reprogramming of mouse somatic
cells. Cell Stem Cell 2, 151–159.
Fischedick, G., Klein, D.C., Wu, G., Esch, D., Hoing, S., Han, D.W.,
Reinhardt, P., Hergarten, K., Tapia, N., Scholer, H.R., et al. (2012).
Zfp296 is a novel, pluripotent-specific reprogramming factor.
PLoS One 7, e34645.
Imamura, M., Miura, K., Iwabuchi, K., Ichisaka, T., Nakagawa, M.,
Lee, J., Kanatsu-Shinohara, M., Shinohara, T., and Yamanaka, S.
(2006). Transcriptional repression and DNA hypermethylation of
a small set of ES cell marker genes in male germline stem cells.
BMC Dev. Biol. 6, 34.
Johannesson, B., Sagi, I., Gore, A., Paull, D., Yamada, M., Golan-
Lev, T., Li, Z., LeDuc, C., Shen, Y., Stern, S., et al. (2014). Compara-
ble frequencies of coding mutations and loss of imprinting in
human pluripotent cells derived by nuclear transfer and defined
factors. Cell Stem Cell 15, 634–642.
Kim, K., Doi, A.,Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Aryee,
M.J., Ji, H., Ehrlich, L.I., et al. (2010). Epigenetic memory in
induced pluripotent stem cells. Nature 467, 285–290.
Kim, S.M., Flasskamp, H., Hermann, A., Arauzo-Bravo, M.J., Lee,
S.C., Lee, S.H., Seo, E.H., Lee, S.H., Storch, A., Lee, H.T., et al.
(2014). Direct conversion of mouse fibroblasts into induced neural
stem cells. Nat. Protoc. 9, 871–881.
Ko, K., Tapia, N., Wu, G., Kim, J.B., Bravo, M.J., Sasse, P., Glaser, T.,
Ruau, D., Han, D.W., Greber, B., et al. (2009). Induction of
pluripotency in adult unipotent germline stem cells. Cell Stem
Cell 5, 87–96.s
Ko, K., Arauzo-Bravo, M.J., Kim, J., Stehling, M., and Scholer, H.R.
(2010). Conversion of adult mouse unipotent germline stem cells
into pluripotent stem cells. Nat. Protoc. 5, 921–928.
Ko, K., Reinhardt, P., Tapia, N., Schneider, R.K., Arauzo-Bravo,M.J.,
Han, D.W., Greber, B., Kim, J., Kliesch, S., Zenke, M., et al. (2011).
Brief report: evaluating the potential of putative pluripotent cells
derived from human testis. Stem Cells 29, 1304–1309.
Ko, K., Wu, G., Arauzo-Bravo, M.J., Kim, J., Francine, J., Greber, B.,
Muhlisch, J., Joo, J.Y., Sabour, D., Fruhwald, M.C., et al. (2012).
Autologous pluripotent stem cells generated from adult mouse
testicular biopsy. Stem Cell Rev. 8, 435–444.
Ma, H., Morey, R., O’Neil, R.C., He, Y., Daughtry, B., Schultz, M.D.,
Hariharan, M., Nery, J.R., Castanon, R., Sabatini, K., et al. (2014).
Abnormalities in human pluripotent cells due to reprogramming
mechanisms. Nature 511, 177–183.
Marthaler, A.G., Tiemann, U., Arauzo-Bravo,M.J.,Wu, G., Zaehres,
H., Hyun, J.K., Han, D.W., Scholer, H.R., and Tapia, N. (2013).
Reprogramming to pluripotency through a somatic stem cell
intermediate. PLoS One 8, e85138.
Meissner, A., Gnirke, A., Bell, G.W., Ramsahoye, B., Lander, E.S.,
and Jaenisch, R. (2005). Reduced representation bisulfite
sequencing for comparative high-resolution DNA methylation
analysis. Nucleic Acids Res. 33, 5868–5877.
Morimoto, H., Lee, J., Tanaka, T., Ishii, K., Toyokuni, S., Ka-
natsu-Shinohara, M., and Shinohara, T. (2012). In vitro trans-
formation of mouse testis cells by oncogene transfection. Biol.
Reprod. 86, 148.StemPolo, J.M., Liu, S., Figueroa, M.E., Kulalert,W., Eminli, S., Tan, K.Y.,
Apostolou, E., Stadtfeld,M., Li, Y., Shioda, T., et al. (2010). Cell type
of origin influences the molecular and functional properties
of mouse induced pluripotent stem cells. Nat. Biotechnol. 28,
848–855.
Tachibana, M., Amato, P., Sparman, M., Gutierrez, N.M., Tippner-
Hedges, R., Ma, H., Kang, E., Fulati, A., Lee, H.S., Sritanaudomchai,
H., et al. (2013). Human embryonic stem cells derived by somatic
cell nuclear transfer. Cell 153, 1228–1238.
Tapia, N., and Scho¨ler, H.R. (2010). p53 connects tumorigenesis
and reprogramming to pluripotency. J. Exp. Med. 207, 2045–2048.
Tiemann, U., Sgodda, M., Warlich, E., Ballmaier, M., Scholer, H.R.,
Schambach, A., and Cantz, T. (2011). Optimal reprogramming fac-
tor stoichiometry increases colony numbers and affects molecular
characteristics of murine induced pluripotent stem cells. Cytome-
try A 79, 426–435.
Tiemann, U., Marthaler, A.G., Adachi, K.,Wu, G., Fischedick, G.U.,
Arauzo-Bravo, M.J., Scholer, H.R., and Tapia, N. (2014). Counter-
acting activities of OCT4 and KLF4 during reprogramming to plu-
ripotency. Stem Cell Rep. 2, 351–365.
Yoshimizu, T., Sugiyama, N., De Felice, M., Yeom, Y.I., Ohbo, K.,
Masuko, K., Obinata, M., Abe, K., Scholer, H.R., and Matsui, Y.
(1999). Germline-specific expression of the Oct-4/green fluores-
cent protein (GFP) transgene in mice. Dev. Growth Differ. 41,
675–684.
Zhao, Q., Wang, J., Zhang, Y., Kou, Z., Liu, S., and Gao, S. (2010).
Generation of histocompatible androgenetic embryonic stem cells
using spermatogenic cells. Stem Cells 28, 229–239.Cell Reports j Vol. 6 j 35–43 j January 12, 2016 j ª2016 The Authors 43
